Brief: Marksans Pharma Says Time-Cap Laboratories Got EIR From US FDA
03/11/2023 05:21
Nov 3 (Reuters) - Marksans Pharma Ltd MARK.NS :
* TIME-CAP LABORATORIES, INC, RECEIVES ESTABLISHMENT
INSPECTION
REPORT FROM US FDA
* NO 483' S WERE ISSUED DURING THE AUDIT
Source text for Eikon: ID:nNSE3Ymvl2
Further company coverage: MARK.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg